Status:
COMPLETED
Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the effectiveness of proactive notifications to treating oncologist to optimize participant accrual to clinical trials by utilizing the MatchMiner AI platform. This study c...
Detailed Description
The goal of this medical record data analysis and health system implementation study is to evaluate the effectiveness of proactive notifications to treating oncologist to optimize participant accrual ...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- adults with any type of cancer whose tumors underwent OncoPanel genomic sequencing from 2013-2022
Exclusion
- ≤ 18 years of age.
Key Trial Info
Start Date :
January 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2024
Estimated Enrollment :
20707 Patients enrolled
Trial Details
Trial ID
NCT06888089
Start Date
January 30 2023
End Date
July 15 2024
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215